News & Updates

Frailty, which is prevalent in the subacute geriatric inpatient population, is independently associated with age, hand grip strength (HGS) at discharge, serum albumin, and urinary incontinence, according to a Singapore study.

Individuals who have trouble falling asleep and who use sleep medications are at increased risk of dementia, as reported in a study.

Using methylphenidate and a selective serotonin reuptake inhibitor (SSRI) together does not appear to pose any significant risk, with both agents having been shown to be safe in adolescent patients with attention deficit-hyperactivity disorder (ADHD) and depression, according to a new-user cohort study.

Treatment with lanadelumab given every 2 or 4 weeks (Q2W or Q4W dosing) reduces the frequency of attacks in patients aged 2 to <12 years with hereditary angioedema (HAE), according to the SPRING study presented at AAAAI 2023.

The use of the novel selective JAK-1 inhibitor upadacitinib appears to result in rapid symptom improvements in patients with difficult-to-treat ulcerative colitis or Crohn’s disease, including those who have prior exposure to tofacitinib, according to real-world data.